Standardization of an assay for the measurement of neutralizing antibodies and analysis of antiviral compounds for SARS-CoV-2, based on a pseudolentivirus.
- Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
- Total publications:0 publications
Grant number: 312404
Grant search
Key facts
Disease
COVID-19Funder
Consejo Nacional de Ciencia y Tecnología (CONACYT)Principal Investigator
N/A
Research Location
MexicoLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Clinical Trials (Research Protocols In Human Beings) To Determine The Safety And Effectiveness Of Treatments (Of Recent Or Redirected Development1) For Covid-19.